NY-ESO-1-Specific TCR Lentivirus (Clone 1G4)

Only %1 left

Catalog #

78675

As low as $1,150 *

Cat # Size Price*

Qty

Bulk/Custom

Add to Favorites

*US Pricing only. For international pricing, please contact your local distributor.

●

Purchase

●

Description

The human NY-ESO-1-specific T Cell Receptor (TCR) lentiviruses (clone 1G4) are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce cells with a human TCR (clone 1G4) that specifically recognizes antigen NY-ESO-1 (New York esophageal squamous cell carcinoma 1), and in which the TCR α chain and β chain are linked by P2A (Figure 1). The lentiviruses also transduce a puromycin selection gene.

Figure 1. (A) Schematic of the lenti-vector used to generate the NY-ESO-1-specific TCR lentivirus and (B) Construct diagram showing expressed components of the NY-ESO-1-specific TCR. TRAV and TRAC correspond to the TCR alpha chain variable and constant regions, respectively, whereas TRBV and TRBC correspond to the TCR beta chain variable and constant regions.

●

Product Data Gallery

Expression of NY-ESO-1-specific TCR in Jurkat cells transduced with the lentivirus.

Expression of NY-ESO-1-specific TCR (clone 1G4) in TCR knockout/NFAT Luciferase Reporter Cell Line confers responsiveness to anti-CD3 agonist and induces NFAT-dependent luciferase activity.

T Cell Activation using T2 cells as APC.

T Cell Activation using A375 cells as APC.

Product Info

Storage and Usage

Citations

Supplied As

≥2 x 10⁷ TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.

Materials Required But Not Supplied

Name	Ordering Information
Thaw Medium 2	BPS Bioscience #60184
Growth Medium 2C	BPS Bioscience #79592
Assay Medium 2D	BPS Bioscience #78755
TCR KO NFAT Luciferase Reporter Jurkat Cell Line	BPS Bioscience #78556
CD8⁺ TCR KO NFAT Luciferase Reporter Jurkat Cell Line	BPS Bioscience #78757
T2 Cell Line	ATCC #CRL-1992
A375 Cells	ATCC #CRL-1619
NY-ESO-1 (157-165) Peptide	BPS Bioscience #78758
MART-1 (Leu26-35, Leu27) Peptide	BPS Bioscience #78760
APC MHC I Dextramer (HLA-A*02:01 SLLMWITQV)	Immudex #WB03247
PE anti-human α/β T Cell Receptor Antibody	BioLegend #306707
ONE-Step™ Luciferase Assay System	BPS Bioscience #60690
Polybrene	Millipore Sigma #TR-1003-G

Formulation

The lentiviruses were produced in HEK293T cells in medium containing 90% DMEM + 10% FBS. Virus particles can be packaged in custom formulations by special request, for an additional fee.

Background

NY-ESO-1 (New York esophageal squamous cell carcinoma 1, also known as Cancer/testis antigen 1, or CTAG1B), is an important tumorigenic marker present in malignant cells. Normally expressed only in embryonic testis, this highly immunogenic protein is not usually found in normal tissues, but is re-expressed in multiple myeloma, non-small cell lung carcinoma, and breast and ovarian cancer, making it a promising candidate antigen for cancer immunotherapy. Several NY-ESO-1-directed therapies are being developed including cancer vaccines, anti-NY-ESO-1 adoptive cell therapy, and NY-ESO-1-specific TCR-T cell therapy in combination with checkpoint inhibitors.

Storage/Stability

Lentiviruses are shipped with dry ice. For long-term storage, it is recommended to store the lentiviruses at -80°C for up to 12 months from date of receipt. Avoid repeated freeze/thaw cycles. Titers can drop significantly with each freeze/thaw cycle.

Growth Media

For best results, the use of BPS Bioscience validated and optimized media is highly recommended. Other preparations or formulations of media may result in suboptimal performance.

Media Required for Maintaining CD8⁺ TCR KO NFAT Luciferase Reporter Cell Line
Growth Medium 2C (BPS Bioscience #79592): RPMI 1640 medium supplemented with 10% FBS, 1% Penicillin/Streptomycin plus 1 mg/ml Geneticin, 100 µg/ml Hygromycin B

Media Required for Maintaining T2 Cell Line
Thaw Medium 2 (BPS Bioscience #60184): RPMI 1640 medium supplemented with 10% FBS, 1% Penicillin/Streptomycin

Media Required for Co-culture Assay
Assay Medium 2D (BPS Bioscience #78755): RPMI 1640 medium supplemented with 1% FBS

Applications

Use as a positive control for NY-ESO-1 TCR evaluation and optimize experimental conditions.
Generate NY-ESO-1 TCR stable cell line (puromycin resistant).

Shipping Temperature

-80°C

Notes

To generate stable TCR-expressing cells, remove the growth medium 48 hours after transduction and replace it with fresh growth medium containing the appropriate amount of puromycin for antibiotic selection of transduced cells. For more information on how to determine the concentration of antibiotic required, see our FAQs resources “what is a kill curve?”

Biosafety
The lentiviruses are produced with a SIN (self-inactivation) lentivector which ensures self-inactivation of the lentiviral construct after transduction and integration into the genomic DNA of the target cells. None of the HIV genes (gag, pol, rev) will be expressed in the transduced cells, as they are expressed from packaging plasmids lacking the packing signal. Although the pseudotyped lentiviruses are replication-incompetent, they require the use of a Biosafety Level 2 facility. BPS recommends following all local federal, state, and institutional regulations and using all appropriate safety precautions.

License Disclosure
Visit bpsbioscience.com/license for the label license and other key information about this product.

Troubleshooting Guide
Visit bpsbioscience.com/lentivirus-faq for detailed troubleshooting instructions. For all further questions, please email [email protected].

Warnings

Avoid freeze/thaw cycles

Scientific Category

CAR T-Cell Therapy

Regulatory Status

Research Use Only

Skip to the end of the images gallery

Skip to the beginning of the images gallery

NY-ESO-1-Specific TCR Lentivirus (Clone 1G4)

PRODUCTS

SERVICES

RESOURCES

COMPANY